US Patent 7572628 Eukaryotic layered vector initiation systems
Patent 7572628 was granted and assigned to Novartis on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Barbara A. Belli0
Carlos E. Ibanez0
David A. Driver0
Douglas J. Jolly0
John M. Polo0
Stephen M. W. Chang0
Thomas W. Dubensky, Jr.0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+231 characters)
Article
Patent abstract
The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07572628 Eukaryotic layered vector initiation systems US Patent 7572628 Eukaryotic layered vector initiation systems
Infobox
Patent Number
07572628
Patent Number
7572628
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07572628 Eukaryotic layered vector initiation systems
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07572628
Date of patent
August 11, 2009
Patent application number
10346880
Date Filed
January 16, 2003
Patent primary examiner
Find more entities like US Patent 7572628 Eukaryotic layered vector initiation systems
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
